Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 4 years ago

Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits

@xconomy.com 4 years ago

Review: Inside the House of Lies at Theranos

@xconomy.com 5 years ago

After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals

@xconomy.com 5 years ago

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

@xconomy.com 5 years ago

Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal

@xconomy.com 5 years ago

After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

@xconomy.com 5 years ago

In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 5 years ago

Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum

@xconomy.com 6 years ago

CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”